While preclinical evidence is promising, translating OncoFlora Immuno-Apoptina® from initial stages to clinical practice requires significant commitment and addressing key research challenges:

° Rigorous In Vivo & Clinical Studies: Essential for all three plant extracts to validate efficacy and safety in living organisms and humans.

° Mechanistic Elucidation & Standardization: In-depth investigation into molecular targets and signaling pathways, along with standardized extraction protocols.

° Advanced Formulations & Delivery Systems: Development of nanocarriers to improve absorption and targeted delivery, leveraging borneol's permeation properties.

° Investigation of Interactions & Resistance: In-depth study of potential drug interactions with conventional chemotherapeutics and monitoring emerging resistance mechanisms.